Assessment of Risk of Depression, Anxiety, and Stress among Type-2 Diabetic Patients on Oral Antidiabetics.
Not Applicable
- Conditions
- Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
- Registration Number
- CTRI/2023/10/059060
- Lead Sponsor
- Justice K S Hegde Charitable Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Subjects on metformin+sulphonylureas/SGLT2I+other OHAs/DPP4I+other OHAs for at least 30 days prior to enrolment in the study
2. Participants who are willing to give consent.
Exclusion Criteria
1. T2DM patients with life-threatening
complications
2. Pregnant women
3. Patients taking SGLT2I, DPP4I in combination.
4. Patients who are severely disabled, deaf, or
mute
5. Patients taking antidepressants
6. Patients with:
(i)Neurological or severe psychiatric disease
(ii)Depression or anxiety with onset prior to
starting OHAs.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression <br/ ><br> <br/ ><br>Timepoint: At baseline visit <br/ ><br>
- Secondary Outcome Measures
Name Time Method FBS <br/ ><br>PPBS <br/ ><br>RBS <br/ ><br>HbA1C <br/ ><br>BP <br/ ><br>HDL <br/ ><br>LDL <br/ ><br>TGs <br/ ><br>TC <br/ ><br>Timepoint: At baseline visit